Beyond the Bench

Angie presents at the 2025 Peds Research Day
Angie shares her work on defining differences in TCR vs next-generation CAR molecules.

Amanda presents at the 2025 Peds Research Day
Amanda presents her research on an exciting CAR therapy to target solid tumors.

Angie presents at the 2025 Immunology Conference
Angie presents her work on characterizing the immune synapse of next generation CAR T cells.

Amanda presents at the 2024 Immunology Conference
Amanda showcases her research on an exciting CAR T cell therapy to target solid tumors, thumbs up on her first poster presentation from the lab.

Haley presents at the 2024 Immunology Conference
Haley presents her work on a novel CAR T cell therapy for targeting Acute Myeloid Leukemia.

Ashley defends her thesis!
Ashley presents her thesis research on the regulation of T cell mitochondrial metabolism via MCJ to enhance adoptive cell therapy.

Cathy presents at the ASH Annual Meeting 2023
Cathy presents her talk entitled, "Restoration of LAT signaling via the ALA-CART platform enhances potency and persistence against Acute Myeloid Leukemia."

Cathy presents at the AACR Annual Meeting 2023
Cathy presents her latest findings on the transcriptional changes induced by LAT signaling in the ALA-CART cell platform.

Cathy presents at the 2022 Winter Pediatric Research Poster Session
Cathy presents her latest work on a novel CAR T cell platform to target antigen-low leukemia.

Haley presents at the 2022 Winter Pediatric Research Poster Session
Haley presents her exciting work on targeting Acute Myeloid Leukemia.

Alex presents at the American Society of Hematology Annual Meeting 2022
Alex shares his exciting findings on the CD19XCD22 CAR.
.jpg)
Ashley presents at the Annual AACR Meeting 2022
Ashley presents her work on improving anti-tumor immune response through modulating T cell metabolism.

Cathy presents at the Annual AACR Meeting 2022
Cathy presents her talk entitled, "A novel adjunctive LAT-activating CAR T (ALA-CART) cell platform demonstrates enhanced antigen sensitivity and eradication of antigen-low leukemia."
